| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Clinical Sciences (T.M.R., R.I., D.-Q.L., O.N., X.J., E.Z., U.B., E.R.) Islet Pathophysiology, Lund University, Clinical Research Centre 90-11, SE-20205 Malmö, Sweden; Institution of Endocrinology (D.-Q.L.), Tianjin University, 300070 Tianjin, China; Department of Pharmacology (O.N.), Alberta Diabetes Institute (ADI), 6040 Health Research Innovation Facility East, Edmonton, Alberta, Canada; and Department of Experimental Medical Science (L.S.), Cell Signalling, Lund University, BMC C11, SE-22100 Lund, Sweden
Address all correspondence to: Thomas M. Reinbothe, Department of Clinical Sciences, Islet Pathophysiology, Lund University, Clinical Research Centre 90-11, SE-20205 Malmö, Sweden. E-mail: thomas.reinbothe{at}med.lu.se. Address reprint requests to E. Renstrom. E-mail: erik.renstrom{at}med.lu.se.
Nicotinamide adenine dinucleotide phosphate (NADPH) enhances Ca2+-induced exocytosis in pancreatic β-cells, an effect suggested to involve the cytosolic redox protein glutaredoxin-1 (GRX-1). We here detail the role of GRX-1 in NADPH-stimulated β-cell exocytosis and glucose-stimulated insulin secretion. Silencing of GRX-1 by RNA interference reduced glucose-stimulated insulin secretion in both clonal INS-1 832/13 cells and primary rat islets. GRX-1 silencing did not affect cell viability or the intracellular redox environment, suggesting that GRX-1 regulates the exocytotic machinery by a local action. By contrast, knockdown of the related protein thioredoxin-1 (TRX-1) was ineffective. Confocal immunocytochemistry revealed that GRX-1 locates to the cell periphery, whereas TRX-1 expression is uniform. These data suggest that the distinct subcellular localizations of TRX-1 and GRX-1 result in differences in substrate specificities and actions on insulin secretion. Single-cell exocytosis was likewise suppressed by GRX-1 knockdown in both rat β-cells and clonal 832/13 cells, whereas after overexpression exocytosis increased by approximately 40%. Intracellular addition of NADPH (0.1 mM) stimulated Ca2+-evoked exocytosis in both cell types. Interestingly, the stimulatory action of NADPH on the exocytotic machinery coincided with an approximately 30% inhibition in whole-cell Ca2+ currents. After GRX-1 silencing, NADPH failed to amplify insulin release but still inhibited Ca2+ currents in 832/13 cells. In conclusion, NADPH stimulates the exocytotic machinery in pancreatic β-cells. This effect is mediated by the NADPH acceptor protein GRX-1 by a local redox reaction that accelerates β-cell exocytosis and, in turn, insulin secretion.
This article has been cited by other articles:
![]() |
E. C. Vanzela, R. A. Ribeiro, C. A. M. de Oliveira, F. B. Rodrigues, M. L. Bonfleur, E. M. Carneiro, K. L. A. Souza, and A. C. Boschero Pregnancy restores insulin secretion from pancreatic islets in cafeteria diet-induced obese rats Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2010; 298(2): R320 - R328. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |